A Study of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease.

NCT06769984 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

TED

Interventions

DRUG: SCTT11
DRUG: Placebo

Sponsor

Sinocelltech Ltd.